EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.4.17.23 | Hemangioma |
33861415 |
?-elemene affects angiogenesis of infantile hemangioma by regulating angiotensin-converting enzyme 2 and hypoxia-inducible factor-1 alpha. |
causal interaction diagnostic usage unassigned |
2 3 0 |
3.4.17.23 | COVID-19 |
34495697 |
A bifluorescent-based assay for the identification of neutralizing antibodies against SARS-CoV-2 variants of concern in vitro and in vivo. |
diagnostic usage ongoing research unassigned |
1 1 0 |
3.4.17.23 | Severe Acute Respiratory Syndrome |
32695320 |
A brand-new cardiorenal syndrome in the COVID-19 setting. |
therapeutic application unassigned |
1 0 |
3.4.17.23 | COVID-19 |
32584474 |
A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19. |
causal interaction ongoing research therapeutic application unassigned |
2 2 4 0 |
3.4.17.23 | Lung Injury |
32584474 |
A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19. |
causal interaction ongoing research therapeutic application unassigned |
2 2 4 0 |
3.4.17.23 | Pneumonia |
32584474 |
A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19. |
causal interaction ongoing research therapeutic application unassigned |
2 2 4 0 |
3.4.17.23 | Infections |
33244671 |
A Case-Control Study of the 2019 Influenza Vaccine and Incidence of COVID-19 Among Healthcare Workers. |
therapeutic application unassigned |
1 0 |
3.4.17.23 | Influenza, Human |
33244671 |
A Case-Control Study of the 2019 Influenza Vaccine and Incidence of COVID-19 Among Healthcare Workers. |
therapeutic application unassigned |
1 0 |
3.4.17.23 | Neoplasms |
32822911 |
A combinational approach to restore cytokine balance and to inhibit virus growth may promote patient recovery in severe COVID-19 cases. |
causal interaction unassigned |
1 0 |
3.4.17.23 | COVID-19 |
33275999 |
A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor. |
causal interaction ongoing research therapeutic application unassigned |
4 3 4 0 |